CD19 and neoplasm: To determine the anti‐tumor activity of sCD19‐SA‐stimulated CD19‐targeted CAR‐T cells in vivo, NSG mice were inoculated with Raji‐Luc‐GFP cells as a xenograft model of Hodgkin's lymphoma.